April 8, 2025   USA
nordiclifescience.org: only winners from a precision medicine approach to Type 1 Diabetes

This article features insights from three key speakers invited by Diamyd Medical for the Women’s Health event hosted by The Life Science Bridge on March 27th, 2025. 

The event explored challenges and advancements in women’s health, particularly in relation to autoimmune conditions like Type 1 Diabetes.

Comments and interviews include Ginger Vieira, author and Type 1 Diabetes patient; Dr. Emily Sims, associate professor of pediatrics, and member of the Diamyd Medical Scientific Advisory Board, and Dr. Karin Rosén, MD, PhD, and Board Member of Diamyd Medical.

Read the article here

Presentations from the event are available here:

Bridging the Gap 2025 - Dr. Karin Rosén, Dr. Emily K. Sims, and Ginger Vieira

Bridging the Gap 2025 - Dr. Ulf Hannelius, President & CEO of Diamyd Medical

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS